Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis

Clinical Infectious Diseases

Volumn 35, Issue 2, 2002, Pages 113-125

  Bisno, Alan L ^a   Gerber, Michael A ^b   Gwaltney, Jack M ^c   Kaplan, Edward L ^e   Schwartz, Richard H ^c,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d INOVA FAIRFAX HOSPITAL FOR CHILDREN   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BENZATHINE PENICILLIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN V; PROCAINE PENICILLIN;

ANTIBIOTIC THERAPY; CLINICAL EXAMINATION; COST BENEFIT ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG SAFETY; HUMAN; PHARYNGITIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS GROUP A; SYMPTOM;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CHILD; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; DISEASE TRANSMISSION; DRUG ADMINISTRATION SCHEDULE; HUMANS; INJECTIONS, INTRAMUSCULAR; PENICILLIN G; PENICILLIN V; PENICILLINS; PHARYNGITIS; PHARYNX; RECURRENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRUS DISEASES;

EID: 0037100250     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340949     Document Type: Review

References (96)

1. Diagnosis and management of group A streptococcal pharyngitis: A practice guideline
2. Treatment of streptococcal pharyngitis with amoxycillin once a day
3. Once-daily therapy for streptococcal pharyngitis with amoxicillin
4. New approaches to the treatment of group A streptococcal pharyngitis
5. Streptococcal pharyngitis: Current therapy and criteria for evaluation of new agents
6. Purpose of quality standards for infectious diseases
7. Acute pharyngitis: Etiology and diagnosis
8. Perplexity and precision in the diagnosis of streptococcal pharyngitis
9. Pharyngitis
10. Do the beta-hemolytic non-group A streptococci cause pharyngitis?
11. Association of group C beta-hemolytic streptococci with endemic pharyngitis among college students
12. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci
13. Community-wide outbreak of group G streptococcal pharyngitis
14. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa
15. Antibody response to Arcanobacterium haemolyticum infection in humans
16. Diagnosis of streptococcal pharyngitis: Differentiation of active infection from the carrier state in the symptomatic child
17. Diagnosis of pharyngitis: Clinical and epidemiologic features
18. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis
19. Streptococcal pharyngitis: Evaluation of clinical syndromes in diagnosis
20. The diagnosis of strep throat in adults in the emergency room
21. A streptococcal score card revisited
22. The accuracy of experienced physicians' probability estimates for patients with sore throats: Implications for decision making
23. The prediction of streptococcal pharyngitis in adults
24. Acute pharyngitis
25. Principles of appropriate antibiotic use of acute pharyngitis in adults
26. Principles of appropriate antibiotic use for acute pharyngitis in adults: Background
27. Antibiotic treatment of adults with sore throat by community primary care physicians
28. The accuracy of diagnosis of beta-streptococcal infections on clinical grounds
29. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal pharyngitis
30. Streptococcal pharyngitis: Optimal site for throat culture
31. Cultures of Streptococcus pyogenes from the oropharynx
32. Effect of atmosphere of incubation on the isolation of group A streptococci from throat cultures
33. Effect of atmosphere and duration of incubation on primary isolation of group A streptococci from throat cultures
34. Comparison of throat culture methods for the recovery of group A streptococci in a pediatric office setting
35. Diagnosis of pharyngitis: Methodology of throat cultures
36. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits
37. Rapid extraction method with pronase B for grouping beta-hemolytic streptococci
38. Bacitracin differentiation of presumptive identification of group A beta-hemolytic streptococci: Comparison of primary and purified plate testing
39. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis
40. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy
41. Clinical evaluation of a latex agglutination test for streptococcal pharyngitis: Performance and impact on treatment rates
42. Antigen detection test for streptococcal pharyngitis: Evaluation of sensitivity with respect to true infections
43. Streptococcal pharyngitis: Diagnostic considerations
44. Diagnosis of group A streptococcal pharyngitis in a private clinic: Comparative evaluation of an optical immunoassay method and culture
45. Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation
46. Rapid detection of Streptococcus pyogenes in pediatric patient specimens by DNA probes
47. Optical immunoassay for rapid detection of group A beta-hemolytic streptococci
48. Group A streptococcal infection
49. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis
50. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract
51. Treatment failures and carriers: Perception or problems?
52. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis
53. Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis
54. The role of streptococcus in the pathogenesis of rheumatic fever
55. Prevention of rheumatic fever: Treatment of the preceding streptococcic infection
56. Prophylaxis of acute rheumatic fever by treatment of preceding streptococcal infection with various amounts of depot penicillin
57. Controlled studies of streptococcal pharyngitis in a pediatric population. I. Factors related to the attack rate of rheumatic fever
58. Prevention of rheumatic fever by treatment of previous streptococcal infections
59. Protection of a military population from rheumatic fever
60. Rheumatic fever in children and adolescents: A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences
61. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
62. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy
63. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: Examination of 301 strains isolated in the United States between 1994 and 1997
64. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh
65. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California
66. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals
67. Clarithromycin suspension vs. penicillin V suspension in children with streptococcal pharyngitis
68. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children
69. 5-Day therapy of bacterial pharyngitis and tonsillitis with cefixime: Comparison with 10-day treatment with penicillin V
70. Short course therapy with ceftibuten versus azithromycin in pediatric streptococcal pharyngitis
71. Five-day cefdinir treatment for streptococcal pharyngitis
72. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis: Ten days of penicillin vs. 5 days or 10 days of cefpodoxime therapy in children
73. Management of pediatric patients with group A beta-hemolytic Streptococcus pharyngitis: Treatment options
74. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin)
75. Failure of once-daily penicillin V therapy for streptococcal pharyngitis
76. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis
77. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis
78. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents
79. Five-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: Comparison with 10-day penicillin V therapy
80. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis
81. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor, and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis
82. Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis
83. Prevention of invasive group A streptococcal disease among household contacts of case patients: Is prophylaxis warranted?
84. Penicillin V for group A streptococcal pharyngotonsillitis: A randomized trial of seven days' versus ten days' therapy
85. Once daily therapy for streptococcal pharyngitis with cefadroxil
86. The group A streptococcal upper respiratory tract carrier state: An enigma
87. Potential mechanisms for failure to eradicate group A streptococci from the pharynx
88. Streptococcal pharyngitis: The case for penicillin therapy
89. Efficacy of tonsillectomy for recurrent throat infection in severely affected children: Results of parallel randomized and nonrandomized clinical trials
90. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci
91. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment
92. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure
93. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci
94. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: A randomized trial of 10 days penicillin vs. 10 days penicillin with rifampin during the final 4 days of therapy